The GoodRx Prescription Savings Blog

The latest updates on prescription drugs and ways to save from the GoodRx medical team

It’s Finally Here, the Generic for Lexapro! Meet Mylan Pharmaceuticals’ Escitalopram

by Dr. Sharon Orrange on March 13, 2012 at 1:35 pm

March 14th will be a great day for those of you who have been paying $50 – $100 a month for Lexapro. The patent for Lexapro runs out this month, and Mylan pharmaceuticals will launch escitalopram, the first generic equivalent to Lexapro.

Escitalopram 5 mg, 10 mg, and 20 mg will be available at a much cheaper price than you have been paying for your Lexapro and that is good news.

Lexapro is a commonly prescribed selective serotonin reuptake inhibitor (SSRI) medication for the acute and maintenance treatment of major depressive disorder in adults and adolescents ages 12 – 17, and for the treatment of generalized anxiety disorder in adults.

Escitalopram, the same medication in generic form, will now be available for the same indications.

Cheers!

Dr. O.

Escitalopram will likely be considered a Tier 1 medication by insurance plans, meaning you’ll pay only your lowest co-pay. Lexapro is covered by some insurance plans as a Tier 2 or 3 medication, meaning a higher copay, but this may change with the introduction of the generic option. Lexapro 10 mg tablets can be found for around $100 for a 30-day supply, up to about $150. Escitalopram 10 mg tablets, in contrast, will start at closer to $80 for a 30-day supply.


Copyright ©2014 GoodRx, Inc.

This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment. Third party logos, trademarks, brand names and images contained on GoodRx.com are for demonstration purposes only and are owned by their respective rights holders, who are not affiliated with this Site.